Karan Garg, MD
Vascular Surgery · New York, NYNPI 1720230287
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Shockwave Medical, Inc at 41.6% of the total. Reporting peaked in 2022 at $72,146 and has fallen 50.9% since, to $35,455 in 2025. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 880 payments — averaging $279.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$102K
- Cook Incorporated$51K
- W. L. Gore & Associates, Inc.$29K
- Inari Medical, Inc.$26K
- Cook Medical LLC$15K
- Penumbra, Inc.$5K
- plus $17K from 28 others
Across 13 payments — averaging $4779.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$32K
- Inari Medical, Inc.$30K
What the payments were for
- Consulting fees$66,62527%
- Speaking & faculty fees$123,63550%
- Travel & lodging$10,1744%
- Food & beverage$44,97218%
- Education$500%
- Entertainment$620%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 89 | $102,242 |
| Cook Incorporated | 21 | $50,932 |
| W. L. Gore & Associates, Inc. | 118 | $29,185 |
| Inari Medical, Inc. | 65 | $26,158 |
| Cook Medical LLC | 326 | $15,210 |
| Penumbra, Inc. | 67 | $5,164 |
| Medtronic(2 entities) | 27 | $3,492 |
| Abbott | 34 | $2,023 |
| Wilson Cook Medical Incorporated | 1 | $1,240 |
| Silk Road Medical, Inc. | 9 | $1,221 |
| Terumo Medical Corporation | 15 | $1,130 |
| Bard Peripheral Vascular, Inc. | 8 | $888 |
| Endologix LLC | 10 | $836 |
| Bolton Medical Inc | 11 | $825 |
| Stryker | 6 | $728 |
| Balt USA, LLC | 6 | $480 |
| Imperative Care, Inc | 5 | $444 |
| Baxter Healthcare | 7 | $427 |
| Kerecis Limited | 1 | $349 |
| Philips North America LLC | 3 | $335 |
| Integra Lifesciences Corporation | 3 | $305 |
| Cardiovascular Systems Inc. | 12 | $304 |
| Boston Scientific | 10 | $268 |
| Medline Industries LP | 4 | $268 |
| Limflow Inc. | 2 | $178 |
| Truvic Medical, Inc. | 4 | $170 |
| Surmodics, Inc. | 1 | $169 |
| Covidien LP | 1 | $167 |
| Getinge USA Sales, LLC | 1 | $126 |
| Pfizer | 4 | $88 |
| Johnson & Johnson | 5 | $84 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Neuros Medical, Inc. | 1 | $28 |
| Reflow Medical Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$101,752
- CT THROMBECTOMY SYSTEM KIT$23,084
- Zenith Alpha$17,554
- Zenith$17,461
- GORE VIABAHN VBX Balloon Expandable Endo$13,722
- Zenith Spiral-Z$12,645
- FLOWTRIEVER CATHETER, S$12,395
- GORE EXCLUDER Iliac Branch Endoprosthesis$8,250
- FlowTriever$7,535
- ClotTriever$7,535
- GORE EXCLUDER AAA Endoprosthesis$6,490
- GORE VIABAHN Endoprosthesis$6,417
- Product in Development$6,068
- VIABAHN Endoprosthesis with PROPATEN Bioactive Surface$4,400
- GORE VIABAHN Endoprosthesis with Heparin$4,180
- Zilver PTX$3,945
- GORE TAG Conformable Thoracic Endoprosthesis$3,352
- Indigo System$2,885
- Cook Medical Zenith$2,212
- ENROUTE Transcarotid Neuroprotection System$1,538
How this compares
$245,518 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 31 | $26,942 |
| XareltoRivaroxaban | 29 | $25,254 |
| ClopidogrelClopidogrel Bisulfate | 153 | $926 |
| Cilostazol | 29 | $312 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $88 | $26,94231 claims |
| Johnson & JohnsonXarelto | $84 | $25,25429 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 405 vascular surgery providers in New York.
Other vascular surgery in New York
- Gary GelbfishNew York$1.9M
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Ajit RaoNew York$294K
- Daniel HanNew York$280K
- Todd BerlandNew York$260K
- Thomas MaldonadoNew York$249K
- Rami TadrosNew York$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.